Details for New Drug Application (NDA): 020013
✉ Email this page to a colleague
The generic ingredient in MAXAQUIN is lomefloxacin hydrochloride. There is one drug master file entry for this compound. Additional details are available on the lomefloxacin hydrochloride profile page.
Summary for 020013
Tradename: | MAXAQUIN |
Applicant: | Pharmacia |
Ingredient: | lomefloxacin hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 400MG BASE | ||||
Approval Date: | Feb 21, 1992 | TE: | RLD: | No |
Expired US Patents for NDA 020013
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pharmacia | MAXAQUIN | lomefloxacin hydrochloride | TABLET;ORAL | 020013-001 | Feb 21, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription